Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    EMBER creates a unified space for independent breast cancer transcriptomic datasets enabling precision oncology

    Transcriptomics has revolutionized biomedical research and refined breast cancer subty** and diagnostics. However, wider use in clinical practice is hampered for a number of reasons including the application...

    Carlos Ronchi, Syed Haider, Cathrin Brisken in npj Breast Cancer (2024)

  2. Article

    Open Access

    Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program

    Research on metastatic cancer has been hampered by limited sample availability. Here we present the breast cancer post-mortem tissue donation program UPTIDER and show how it enabled sampling of a median of 31 ...

    Tatjana Geukens, Maxim De Schepper, Wouter Van Den Bogaert in npj Breast Cancer (2024)

  3. Article

    Open Access

    TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression

    Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. Virtually all women with DCIS are treated, despite evidence suggesting up to half would remain with stable, non-threatenin...

    Shayin V. Gibson, Elena Tomas Bort, Lucía Rodríguez-Fernández in npj Breast Cancer (2023)

  4. Article

    Open Access

    Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence

    More than 70% of human breast cancers (BCs) are estrogen receptor α-positive (ER+). A clinical challenge of ER+ BC is that they can recur decades after initial treatments. Mechanisms governing latent disease rema...

    Patrick Aouad, Yueyun Zhang, Fabio De Martino, Céline Stibolt in Nature Communications (2022)

  5. Article

    Open Access

    RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

    Multigene assays for molecular subtypes and biomarkers can aid management of early invasive breast cancer. Using RNA-sequencing we aimed to develop single-sample predictor (SSP) models for clinical markers, su...

    Johan Staaf, Jari Häkkinen, Cecilia Hegardt, Lao H. Saal in npj Breast Cancer (2022)

  6. Article

    Open Access

    ADAMTS18+ villus tip telocytes maintain a polarized VEGFA signaling domain and fenestrations in nutrient-absorbing intestinal blood vessels

    The small intestinal villus tip is the first point of contact for lumen-derived substances including nutrients and microbial products. Electron microscopy studies from the early 1970s uncovered unusual spatial...

    Jeremiah Bernier-Latmani, Cristina Mauri, Rachel Marcone in Nature Communications (2022)

  7. Article

    Open Access

    Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor

    Estrogen and progesterone receptor (ER, PR) signaling control breast development and im**e on breast carcinogenesis. ER is an established driver of ER + disease but the role of the PR, itself an ER target ge...

    Valentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino in Nature Communications (2022)

  8. Article

    Open Access

    Deep Learning Enables Individual Xenograft Cell Classification in Histological Images by Analysis of Contextual Features

    Patient-Derived Xenografts (PDXs) are the preclinical models which best recapitulate inter- and intra-patient complexity of human breast malignancies, and are also emerging as useful tools to study the normal ...

    Quentin Juppet, Fabio De Martino in Journal of Mammary Gland Biology and Neopl… (2021)

  9. Article

    Open Access

    A novel culture method that sustains ERα signaling in human breast cancer tissue microstructures

    Estrogen receptor α (ERα) signaling is a defining and driving event in most breast cancers; ERα is detected in malignant epithelial cells of 75% of all breast cancers (classified as ER-positive breast cancer) ...

    Ana Luísa Cartaxo, Marta F. Estrada in Journal of Experimental & Clinical Cancer … (2020)

  10. Article

    Open Access

    The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche

    Estrogens and progesterone control breast development and carcinogenesis via their cognate receptors expressed in a subset of luminal cells in the mammary epithelium. How they control the extracellular matrix,...

    Dalya Ataca, Patrick Aouad, Céline Constantin, Csaba Laszlo in Nature Communications (2020)

  11. Article

    Open Access

    Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium

    Oestrogen receptor α (ERα) is a transcription factor with ligand-independent and ligand-dependent activation functions (AF)-1 and -2. Oestrogens control postnatal mammary gland development acting on a subset o...

    Stéphanie Cagnet, Dalya Ataca, George Sflomos, Patrick Aouad in Nature Communications (2018)

  12. No Access

    Protocol

    Analysis of Mammary Gland Phenotypes by Transplantation of the Genetically Marked Mammary Epithelium

    The mammary gland is the only organ to undergo most of its development after birth and therefore particularly attractive for studying developmental processes. In the mouse, powerful tissue recombination techni...

    Duje Buric, Cathrin Brisken in Mammary Gland Development (2017)

  13. No Access

    Chapter

    Breast Cancer Microenvironment and the Metastatic Process

    Metastases are the main cause of breast cancer-related death: hence, the clinical need to prevent and to stop metastasis is of outmost importance. Evidence has accumulated that the propensity of breast cancer ...

    George Sflomos, Cathrin Brisken in Breast Cancer (2017)

  14. No Access

    Article

    Patient-derived xenograft (PDX) models in basic and translational breast cancer research

    Patient-derived xenograft (PDX) models of a growing spectrum of cancers are rapidly supplanting long-established traditional cell lines as preferred models for conducting basic and translational preclinical re...

    Lacey E. Dobrolecki, Susie D. Airhart, Denis G. Alferez in Cancer and Metastasis Reviews (2016)

  15. Article

    Correction: Corrigendum: Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation

    Nat. Cell Biol. 17, 1193–1204 (2015); published online 24 August 2015; corrected after print 28 August 2015 An error in the print version of this Article meant that Witold W. Kilarski's name was incorrect. Thi...

    Maria-Giuseppina Procopio, Csaba Laszlo, Dania Al Labban in Nature Cell Biology (2015)

  16. No Access

    Article

    Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation

    Stromal fibroblast senescence has been linked to ageing-associated cancer risk. However, density and proliferation of cancer-associated fibroblasts (CAFs) are frequently increased. Loss or downmodulation of th...

    Maria-Giuseppina Procopio, Csaba Laszlo, Dania Al Labban in Nature Cell Biology (2015)

  17. Article

    Reply to Is progesterone a neutral or protective factor for breast cancer?

    Cathrin Brisken in Nature Reviews Cancer (2014)

  18. No Access

    Article

    Progesterone signalling in breast cancer: a neglected hormone coming into the limelight

  19. Mutations are not always sufficient to drive breast carcinogenesis but additional factors determine whether genetically altered cells progress to the state dur...

  20. Cathrin Brisken in Nature Reviews Cancer (2013)

  21. No Access

    Article

    Does Cancer Start in the Womb? Altered Mammary Gland Development and Predisposition to Breast Cancer due to in Utero Exposure to Endocrine Disruptors

    We are now witnessing a resurgence of theories of development and carcinogenesis in which the environment is again being accepted as a major player in phenotype determination. Perturbations in the fetal enviro...

    Ana M. Soto, Cathrin Brisken in Journal of Mammary Gland Biology and Neopl… (2013)

  22. Article

    ER and PR signaling nodes during mammary gland development

    The ovarian hormones estrogen and progesterone orchestrate postnatal mammary gland development and are implicated in breast cancer. Most of our understanding of the molecular mechanisms of estrogen receptor (E...

    Tamara Tanos, Lucia Jimenez Rojo, Pablo Echeverria in Breast Cancer Research (2012)

previous disabled Page of 2